Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in diabetic nephropathy (ARTS-DN)
NCT01874431Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 2 trial of finerenone in diabetic nephropathy (DN), sponsored by Bayer. Started Jun 2013; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01874431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01874431.